Skip to main content
. 2012 Dec 19;15(2):354–366. doi: 10.1208/s12248-012-9436-4

Table IV.

Summary of Crizotinib Effective Concentration Estimates for Target Modulation and Antitumor Efficacy in Mouse Xenograft Models with H3122 NSCLC or GTL16 GC Cells

Xenograft Model PD Parameter EC 50,vitro EC 50,vivo EC 90,vivo
nM free nM free nM free
H3122 NSCLC ALK 60 19
TGI 20
GTL16 GC MET 10 1.5 13
TGI 17

–, not calculated